中度至重度牛皮的治疗顺序:医院基础的回顾性分析
Angela Boccia1, Valentina Giunchi1, Luca Girau1
1Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Expert opinion on biological therapy
|July 31, 2025
概括
在对中度至重度牛皮患者的现实研究中,乌斯特基努马布治疗时间最长. 这表明ustekinumab可能是有效管理牛皮的持久生物治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据研究研究.
背景情况:
- 在传统疗法失败后,建议对中度至重度的牛皮进行生物治疗.
- 疗效的丧失是生物制剂的常见挑战,往往需要切换治疗.
- 这项研究检查了使用生物疗法治疗牛皮的现实世界管理.
研究的目的:
- 探索中度至重度牛皮的现实世界治疗管理.
- 调查影响牛皮患者生物治疗持续时间的因素.
- 评估不同生物制剂的耐用性.
主要方法:
- 对接受生物制剂的成年患者健康记录的回顾性分析.
- 状态序列分析,以调查治疗序列.
- 使用香农的线性回归模型来确定影响治疗持续时间的因素.
主要成果:
- 包括364名患者;阿达利穆马布是最常见的一线生物药物.
- 几乎一半的患者 (48%) 转换了生物治疗.
- 乌斯特基努马布显示了最长的中位治疗持续时间 (1,841天),超过了埃坦塞普特 (639天).
结论:
- 乌斯特基努马布在现实世界牛皮管理中表现出显著更长的治疗持续时间.
- 这些发现支持乌斯特基努马布作为一种持久治疗选择的潜力.
- 进一步的研究可以在不同患者群体中验证这些发现.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:26Nephrotic Syndrome II : Assessment and Medical Management
23
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
23